Review
Open access
Systematic Review: Inclusion of Patients With Difficult‐to‐Treat Inflammatory Bowel Disease in Randomized Controlled Trials of Advanced Therapies
Oct 2026 · Alimentary Pharmacology and Therapeutics · Vol 64, pp. 1379 - 1389 · 0 citations
· 60 references
Medicine
Abstract
Criteria to define difficult‐to‐treat (DTT) inflammatory bowel disease (IBD) have recently been proposed, yet the inclusion and participation of patients with DTT‐IBD in randomized controlled trials (RCTs) are heterogeneous and poorly defined.